• 56 days Could Crypto Overtake Traditional Investment?
  • 61 days Americans Still Quitting Jobs At Record Pace
  • 63 days FinTech Startups Tapping VC Money for ‘Immigrant Banking’
  • 66 days Is The Dollar Too Strong?
  • 66 days Big Tech Disappoints Investors on Earnings Calls
  • 67 days Fear And Celebration On Twitter as Musk Takes The Reins
  • 69 days China Is Quietly Trying To Distance Itself From Russia
  • 69 days Tech and Internet Giants’ Earnings In Focus After Netflix’s Stinker
  • 73 days Crypto Investors Won Big In 2021
  • 73 days The ‘Metaverse’ Economy Could be Worth $13 Trillion By 2030
  • 74 days Food Prices Are Skyrocketing As Putin’s War Persists
  • 76 days Pentagon Resignations Illustrate Our ‘Commercial’ Defense Dilemma
  • 77 days US Banks Shrug off Nearly $15 Billion In Russian Write-Offs
  • 80 days Cannabis Stocks in Holding Pattern Despite Positive Momentum
  • 81 days Is Musk A Bastion Of Free Speech Or Will His Absolutist Stance Backfire?
  • 81 days Two ETFs That Could Hedge Against Extreme Market Volatility
  • 83 days Are NFTs About To Take Over Gaming?
  • 84 days Europe’s Economy Is On The Brink As Putin’s War Escalates
  • 87 days What’s Causing Inflation In The United States?
  • 88 days Intel Joins Russian Exodus as Chip Shortage Digs In
  1. Home
  2. Investing
  3. Other

Big Tobacco Just Can’t Catch A Break

Big Tobacco

In the throes of a vaping panic that has the FDA and the CDC running in frantic circles, tobacco giant Altria has seen its shares tumble almost 20 percent this year, after making a multi-billion-dollar bet on e-cigarette darling Juul.

Last year, Altria paid $12.8 billion for a 35-percent stake in Juul. This year, that investment is looking like one of the worst best the tobacco giant could have made.

Now, Altria’s shares have hit a five-year low …

(Click to enlarge)

And in recent weeks, the sell-off has been gaining momentum as health officials loudly scrutinize eight deaths allegedly linked to vaping and hundreds of illnesses, and as politicians start issuing bans.

So far, vaping is suspected or confirmed as the cause of death for 8 people and 530 cases of pulmonary illness across 38 US states

Juul, which boasts a 75-percent share in the U.S. e-cigarette market--has come under particular scrutiny and is under immense pressure right now from the public, the FDA and even Trump.

Gun control issues haven’t even come close to this amount of attention, even with a spate of killing rampages.

Health officials are still unsure what exactly is causing the illnesses. Related: Insurance Businesses Are Fleeing The UK In Droves

The FDA has pointed to vitamin E acetate in THC vaping cartridges. On Thursday, FDA launched a criminal investigation into the nationwide epidemic of vaping-related illnesses. The Centers for Disease Control and Prevention (CDC) is advising people to stop vaping until the causes are solidly linked or not linked to e-cigarettes.

Last week, Trump proposed banning all flavored vaping pods from the U.S. market. JUUL’s products have already been withdrawn from Chinese major e-commerce websites, and a handful of other countries have introduced restrictions, as well.

India banned e-cigarettes entirely, which could proof to be significant since India has 106 million smokers, second only to China.

Suddenly, in a matter of days, the global vaping market has shrunken exponentially.

It is in this atmosphere that another mega-merger is in the pipeline: This is a re-marriage of sorts, between Altria and Philip Morris, which split in 2007.

Philip Morris has also taken its plunge into the e-cigarette market, and its ongoing development is likely to take some important cues from what’s happening right now on the vaping scene.

It’s been a roller coaster ride for big tobacco. Just think: In 2018, the tobacco industry took a massive, $127-billion hit because of the growing popularity of e-cigarettes. And then the minute they jump on that train to make up for losses, e-cigarettes lose traction over a major health scare. 

By Michael Kern for Safehaven.com

More Top Reads From Safehaven.com:

Back to homepage

Leave a comment

Leave a comment